| Autor: |
Lia, K., Jørgensen, R. R. K., Wold, B. L., Fluge, Ø., Fagerli, U., Bersvendsen, H., Bø, I. B., Bhargava, S., Fosså, A. |
| Předmět: |
|
| Zdroj: |
Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p370-371, 2p |
| Abstrakt: |
B Background: b Elderly Hodgkin Lymphoma (HL) patients (pts) are poorly characterized and underrepresented in high-quality studies. Hospital and other health-care records were reviewed and pts grouped according to treatment into ineligible (no HL directed treatment), palliative (intended dose intensity <50%) or curative (>50% intended dose intensity of HL regimens or curative radiotherapy only). B Conclusion: b In this national population-based study, 32% of pts received either palliative or no treatment directed specifically at HL, and these accounted for a substantial proportion of excess mortality of HL. 10% of pts had other previous or concomitant malignant lymphoproliferative diseases. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text